company background image
2877 logo

China Shineway Pharmaceutical Group SEHK:2877 Rapporto sulle azioni

Ultimo prezzo

HK$8.26

Cap. di mercato

HK$6.3b

7D

2.0%

1Y

14.7%

Aggiornato

20 Aug, 2024

Dati

Dati finanziari dell'azienda +

China Shineway Pharmaceutical Group Limited

SEHK:2877 Rapporto sulle azioni

Cap. di mercato: HK$6.3b

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

2877 Panoramica delle azioni

China Shineway Pharmaceutical Group Limited, una holding di investimento, si occupa di ricerca e sviluppo, produzione e commercio di farmaci cinesi nella Repubblica Popolare Cinese e a Hong Kong.

2877 analisi fondamentale
Punteggio fiocco di neve
Valutazione5/6
Crescita futura3/6
Prestazioni passate5/6
Salute finanziaria5/6
Dividendi4/6

China Shineway Pharmaceutical Group Limited Concorrenti

Storia dei prezzi e prestazioni

Riepilogo dei massimi storici, delle variazioni e dei cali di prezzo di tutti i tempi per China Shineway Pharmaceutical Group
Prezzi storici delle azioni
Prezzo attuale dell'azioneHK$8.26
Massimo di 52 settimaneHK$10.72
Minimo di 52 settimaneHK$6.55
Beta0.79
1Variazione di 1 mese3.51%
Variazione a 3 mesi-10.12%
Variazione di 1 anno14.72%
3Variazione a 3 anni8.68%
Variazione a 5 anni35.19%
Variazione dall'IPO71.19%

Notizie e aggiornamenti recenti

If EPS Growth Is Important To You, China Shineway Pharmaceutical Group (HKG:2877) Presents An Opportunity

Jun 03
If EPS Growth Is Important To You, China Shineway Pharmaceutical Group (HKG:2877) Presents An Opportunity

Is China Shineway Pharmaceutical Group (HKG:2877) A Risky Investment?

May 13
Is China Shineway Pharmaceutical Group (HKG:2877) A Risky Investment?

China Shineway Pharmaceutical Group (HKG:2877) Has Announced That It Will Be Increasing Its Dividend To CN¥0.461

Apr 26
China Shineway Pharmaceutical Group (HKG:2877) Has Announced That It Will Be Increasing Its Dividend To CN¥0.461

Recent updates

If EPS Growth Is Important To You, China Shineway Pharmaceutical Group (HKG:2877) Presents An Opportunity

Jun 03
If EPS Growth Is Important To You, China Shineway Pharmaceutical Group (HKG:2877) Presents An Opportunity

Is China Shineway Pharmaceutical Group (HKG:2877) A Risky Investment?

May 13
Is China Shineway Pharmaceutical Group (HKG:2877) A Risky Investment?

China Shineway Pharmaceutical Group (HKG:2877) Has Announced That It Will Be Increasing Its Dividend To CN¥0.461

Apr 26
China Shineway Pharmaceutical Group (HKG:2877) Has Announced That It Will Be Increasing Its Dividend To CN¥0.461

Are Investors Undervaluing China Shineway Pharmaceutical Group Limited (HKG:2877) By 41%?

Apr 17
Are Investors Undervaluing China Shineway Pharmaceutical Group Limited (HKG:2877) By 41%?

China Shineway Pharmaceutical Group (HKG:2877) Is Increasing Its Dividend To CN¥0.461

Mar 31
China Shineway Pharmaceutical Group (HKG:2877) Is Increasing Its Dividend To CN¥0.461

China Shineway Pharmaceutical Group Limited's (HKG:2877) 26% Price Boost Is Out Of Tune With Earnings

Mar 14
China Shineway Pharmaceutical Group Limited's (HKG:2877) 26% Price Boost Is Out Of Tune With Earnings

Does China Shineway Pharmaceutical Group (HKG:2877) Deserve A Spot On Your Watchlist?

Jan 29
Does China Shineway Pharmaceutical Group (HKG:2877) Deserve A Spot On Your Watchlist?

China Shineway Pharmaceutical Group (HKG:2877) Seems To Use Debt Rather Sparingly

Sep 28
China Shineway Pharmaceutical Group (HKG:2877) Seems To Use Debt Rather Sparingly

China Shineway Pharmaceutical Group (HKG:2877) Is Paying Out A Dividend Of CN¥0.118

Sep 01
China Shineway Pharmaceutical Group (HKG:2877) Is Paying Out A Dividend Of CN¥0.118

We Ran A Stock Scan For Earnings Growth And China Shineway Pharmaceutical Group (HKG:2877) Passed With Ease

Aug 03
We Ran A Stock Scan For Earnings Growth And China Shineway Pharmaceutical Group (HKG:2877) Passed With Ease

Are Investors Undervaluing China Shineway Pharmaceutical Group Limited (HKG:2877) By 44%?

May 30
Are Investors Undervaluing China Shineway Pharmaceutical Group Limited (HKG:2877) By 44%?

We Ran A Stock Scan For Earnings Growth And China Shineway Pharmaceutical Group (HKG:2877) Passed With Ease

Mar 07
We Ran A Stock Scan For Earnings Growth And China Shineway Pharmaceutical Group (HKG:2877) Passed With Ease

China Shineway Pharmaceutical Group's (HKG:2877) Dividend Will Be Reduced To CN¥0.125

Sep 01
China Shineway Pharmaceutical Group's (HKG:2877) Dividend Will Be Reduced To CN¥0.125

China Shineway Pharmaceutical Group Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Mar 31
China Shineway Pharmaceutical Group Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

China Shineway Pharmaceutical Group (HKG:2877) Has A Rock Solid Balance Sheet

Apr 07
China Shineway Pharmaceutical Group (HKG:2877) Has A Rock Solid Balance Sheet

China Shineway Pharmaceutical Group's(HKG:2877) Share Price Is Down 55% Over The Past Three Years.

Mar 11
China Shineway Pharmaceutical Group's(HKG:2877) Share Price Is Down 55% Over The Past Three Years.

Should You Buy China Shineway Pharmaceutical Group Limited (HKG:2877) For Its Dividend?

Feb 18
Should You Buy China Shineway Pharmaceutical Group Limited (HKG:2877) For Its Dividend?

Should You Use China Shineway Pharmaceutical Group's (HKG:2877) Statutory Earnings To Analyse It?

Jan 31
Should You Use China Shineway Pharmaceutical Group's (HKG:2877) Statutory Earnings To Analyse It?

Is China Shineway Pharmaceutical Group Limited (HKG:2877) Trading At A 49% Discount?

Jan 13
Is China Shineway Pharmaceutical Group Limited (HKG:2877) Trading At A 49% Discount?

What Is The Ownership Structure Like For China Shineway Pharmaceutical Group Limited (HKG:2877)?

Dec 25
What Is The Ownership Structure Like For China Shineway Pharmaceutical Group Limited (HKG:2877)?

We Think China Shineway Pharmaceutical Group (HKG:2877) Can Manage Its Debt With Ease

Dec 10
We Think China Shineway Pharmaceutical Group (HKG:2877) Can Manage Its Debt With Ease

Reflecting on China Shineway Pharmaceutical Group's (HKG:2877) Share Price Returns Over The Last Five Years

Nov 25
Reflecting on China Shineway Pharmaceutical Group's (HKG:2877) Share Price Returns Over The Last Five Years

Rendimenti per gli azionisti

2877HK PharmaceuticalsHK Mercato
7D2.0%1.8%2.4%
1Y14.7%13.4%6.2%

Ritorno vs Industria: 2877 ha superato il Hong Kong Pharmaceuticals che ha restituito 13.4 % nell'ultimo anno.

Rendimento vs Mercato: 2877 ha superato il mercato Hong Kong che ha restituito 6.2 % nell'ultimo anno.

Volatilità dei prezzi

Is 2877's price volatile compared to industry and market?
2877 volatility
2877 Average Weekly Movement4.3%
Pharmaceuticals Industry Average Movement5.0%
Market Average Movement6.3%
10% most volatile stocks in HK Market13.3%
10% least volatile stocks in HK Market3.4%

Prezzo delle azioni stabile: 2877 non ha avuto una volatilità dei prezzi significativa negli ultimi 3 mesi.

Volatilità nel tempo: La volatilità settimanale ( 4% ) di 2877 è rimasta stabile nell'ultimo anno.

Informazioni sull'azienda

FondatoI dipendentiAMMINISTRATORE DELEGATOSito web
20023,436n/awww.shineway.com

China Shineway Pharmaceutical Group Limited, una holding di investimento, si occupa di ricerca e sviluppo, produzione e commercio di farmaci cinesi nella Repubblica Popolare Cinese e a Hong Kong. L'azienda offre farmaci cinesi sotto forma di iniezione, capsule molli e granuli; compresse, pillole, liquidi orali e polveri; granuli di medicina tradizionale cinese in varie aree terapeutiche, tra cui malattie del sistema respiratorio, del sistema nervoso, dell'apparato digerente, cardiovascolare e cerebrovascolare, ortopedia, pediatria e altre aree, nonché farmaci per il rafforzamento del corpo. L'azienda si occupa anche di commercio di prodotti agricoli e di ricerca e sviluppo di prodotti farmaceutici cinesi.

China Shineway Pharmaceutical Group Limited Riepilogo dei fondamenti

Come si confrontano gli utili e i ricavi di China Shineway Pharmaceutical Group con la sua capitalizzazione di mercato?
2877 statistiche fondamentali
Capitalizzazione di mercatoHK$6.28b
Guadagni(TTM)HK$1.06b
Ricavi(TTM)HK$4.93b

5.9x

Rapporto P/E

1.3x

Rapporto P/S

Guadagni e ricavi

Statistiche chiave sulla redditività dall'ultima relazione sugli utili (TTM)
2877 Conto economico (TTM)
RicaviCN¥4.52b
Costo del fatturatoCN¥1.12b
Profitto lordoCN¥3.39b
Altre speseCN¥2.42b
GuadagniCN¥969.51m

Ultimi guadagni dichiarati

Dec 31, 2023

Prossima data di guadagno

Aug 29, 2024

Utile per azione (EPS)1.28
Margine lordo75.15%
Margine di profitto netto21.47%
Rapporto debito/patrimonio netto4.3%

Come si è comportato 2877 nel lungo periodo?

Vedi performance storica e confronto

Dividendi

7.0%

Rendimento attuale del dividendo

33%

Rapporto di remunerazione